On February 14, 2022, Kawin and YiChang HEC ChangJiang Pharmaceutical Co.,Ltd. (hereinafter referred to as HEC Pharm 东 阳...
In May 2017, Kawin Technology initiated a phase 3 trial program to investigate use of KW-136, an investigational DAA agai...
On April 13th, 2017, China Food and Drug Administration (CFDA) Center for Drug Evaluation (CDE) announced the fifteenth b...
Beijing Intellectual Property Office announces the results of No. 6th group of Beijing Patent Demonstration Enterprises o...
Kawin Technology was chosen as Beijing Biochemical Spanning Development Engineering Corporation (G20). G20 Engineering is...
Innovative Talents Promoting Project is aimed at cultivating and generating genius involving scientists, technologists an...
Five years ago, two production lines, biochemical products injection and pharmaceutical preparation has acquired INVIMA G...
京公网安备 11030102010708号